MFDS
- Status: likely_approved
🇰🇷 Steglatro in South Korea
Steglatro (ERTUGLIFLOZIN) regulatory status in South Korea.
Marketing authorisation
Steglatro in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Steglatro approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Steglatro in South Korea?
Merck & Co. is the originator. The local marketing authorisation holder may differ — check the official source linked above.